BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
G-protein-coupled receptor binding
,
Breast Cancer
,
Stem cell
,
Biofuel
,
Rapamycin
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
erythema multiforme
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
HLA-B
HLA-A
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
MHC class I, alpha chain, C-terminal
KUROKAWA_LIVER_CANCER_EARLY_RECURRENCE_DN
REACTOME_ENDOSOMAL_VACUOLAR_PATHWAY
MHC class I protein complex
MODULE_293
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
OMIM - Hypersensitivity
Blister cells and PBMCs from patients with SJS-TEN
OMIM - Stevens-Johnson syndrome
Explore Curated Studies Results
Literature
Most Relevant Literature
Multiform exudative erythema caused by hydroxychloroquine, diagnosed by epicutaneous tests: A case r…
A case of erythema multiforme developing after levetiracetam therapy.
Erythema multiforme as first sign of incomplete Kawasaki disease.
Recurrent erythema multiforme triggered by herpes simplex virus].
Urticaria multiforme is a variation of urticaria, which imitates erythema multiforme].
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Apremilast for Erythema Multiforme
Avastin/Temozolomide/Irinotecan for Unresectable/Multifocal Glioblastoma Multiforme
Radiation Therapy With or Without Temozolomide in Treating Older Patients With Newly Diagnosed Gliob…
Vorinostat and Bortezomib in Treating Patients With Progressive, Recurrent Glioblastoma Multiforme
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multifor…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ